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Introduction {#sec005}
============

African countries are burdened with a very heavy load of communicable diseases in addition to other severe health problems \[[@pone.0143999.ref001]\]. Clinically, influenza infection is not distinguishable from numerous other tropical infectious diseases involving fever. In the absence of laboratory confirmation, febrile illnesses are most often treated empirically as malaria. However, numerous studies show that influenza is prevalent in African regions \[[@pone.0143999.ref002],[@pone.0143999.ref003]\]. In 2005, as a consequence of World Health Organization (WHO) advocacy, international resources were mobilized to help African countries respond to the threat of avian influenza. This involved the implementation and enhancement of influenza surveillance tools including the collection and analysis of virological and epidemiological data \[[@pone.0143999.ref003]--[@pone.0143999.ref011]\].

Every year, malaria and respiratory infections are among the leading causes of morbidity and mortality in Africa. In 2008, 99% of all deaths of children \<5 years old associated with influenza infection occurred in developing countries \[[@pone.0143999.ref012]\]. The disease burden of influenza is undoubtedly far greater in Africa than in the developed world, owing to malnutrition and underlying tropical diseases which complicate the infection \[[@pone.0143999.ref013]\]. Influenza causes a significant burden of disease in countries throughout the tropics despite having historically been perceived as a mild or uncommon disease \[[@pone.0143999.ref003],[@pone.0143999.ref014]--[@pone.0143999.ref017]\]. Data from tropical Asian countries show that rates of hospitalization and mortality specifically associated with influenza are similar to those in the United States \[[@pone.0143999.ref018],[@pone.0143999.ref019]\]. In Sub-Saharan Africa, knowledge about the influenza burden is still limited \[[@pone.0143999.ref002]\], although work has started to address the issue of influenza in Africa \[[@pone.0143999.ref011]\].

Data about incidence and mortality are required as a basis for designing and implementing influenza control programs in Africa \[[@pone.0143999.ref020]\]. However, the gaps in the data for Africa are substantial, larger than in other tropical settings, and the data available about the burden of influenza are scarce \[[@pone.0143999.ref021]\]. Existing data, mostly from surveillance, are insufficient to provide meaningful estimates of influenza incidence. Prospective, multi-year, population-based data on laboratory-confirmed influenza infection taking into account malaria epidemiology are needed to describe the disease burden in African countries and provide information for prevention and control strategies during both inter-pandemic and pandemic periods \[[@pone.0143999.ref022]\].

Senegal is an equatorial country in West Africa with a mostly tropical climate; data are available from influenza surveillance in Dakar since 1996 thanks to a collaboration between the Ministry of Health and the Pasteur Institute in Dakar \[[@pone.0143999.ref004],[@pone.0143999.ref008]\]. However, neither the disease burden nor the population at risk are well described. To rectify this situation, we tried to estimate the incidence of fever syndromes, influenza like illnesses and influenza infections in different age groups.

Methods {#sec006}
=======

Study design {#sec007}
------------

Between 1^st^ January 2012 and 31^th^ December 2013, we extended the prospective population-based study involving the inhabitants of the villages of Dielmo and Ndiop, Senegal: we implemented an additional longitudinal study of influenza, involving analysis of all febrile syndromes.

Setting {#sec008}
-------

The two villages, Dielmo and Ndiop, are located in a Sudan-savanna region of central Senegal, in the health district of Sokone. This rural setting has been used for extensive malaria studies \[[@pone.0143999.ref023]\].

Participants {#sec009}
------------

As part of the study designed in to investigate malaria, all episodes of fever among all the population of the two villages included in the cohort (n = 1036) were identified and recorded by fieldworkers.

Follow-up {#sec010}
---------

The cohort has been described elsewhere \[[@pone.0143999.ref023]\]. Each participant had an individual identification code for all the studies. On entry, socio economic information, the location of the residence in the villages and the size of the family were recorded. Field workers visited each household daily, 6 days/week (not on Sundays) to collect information about the presence or absence in the village of each cohort participant, their location when absent, and the presence of fever or other symptoms.

Free medical dispensaries were established in each of the two villages, and were open 24h/day, 7 days/week. All fever syndromes and fever-related symptoms identified by the fieldworkers were systematically examined, investigated and treated. Malaria testing (thick blood smears) was done by finger prick for all febrile cases. The study included systematic collection and testing of swabs from individuals with fever, not only from patients with influenza-like illness.

Cases definition {#sec011}
----------------

In accordance with the sentinel surveillance system in Senegal \[[@pone.0143999.ref004]\] based on clinical pre-diagnostic data using standard WHO case definitions to ensure comparability, case definitions for the study were: fever (defined as an axillary temperature of more than 37.5° C), confirmed malaria cases (defined as fever and a positive result in a rapid diagnostic test), and influenza-like illness (defined as fever with cough or fever with sore throat).

Virological analysis {#sec012}
--------------------

Naso-pharyngeal and oral specimens were collected from all febrile patients included in the cohort in each village, put in 2 mL of viral transport medium (Universal Transport Medium, COPAN Diagnostics), and stored at 4°C before shipment to the NIC on a weekly basis. Samples were shipped at a controlled temperature (4°C) and processed immediately on arrival at the laboratory for virus detection, identification, and characterization by a real-time reverse-transcription polymerase chain reaction method (courtesy of the Centers for Disease Control \[CDC\], Atlanta).

Statistical analysis {#sec013}
--------------------

R software was used for statistical analysis \[[@pone.0143999.ref024]\]. We monitored the presence of each person in the village daily, and we measured the person-time incidence rates of febrile syndromes, influenza-like syndromes, malaria and influenza infection as a ratio: the number of fever episodes recorded during a given period divided by the number of person-days of follow-up included in the survey during the corresponding period. Mean annual incidence rates by period and by age group were calculated from the daily incidence rates on the basis of 365.25 days per year.

To take into account the overdispersion of the data, we used binomial negative regression to measure the relation between the incidence rate and the various covariates studied (age, gender, village.). All covariates with a p value lower than 0.20 were included in the multivariable model. Multivariable backward step-by-step binomial negative regressions were used to take into account confounders, bias, and interactions linked to the dependent variable. The \[20--49 year) group was used as a reference group for comparisons between age group because of the lowest incidence density rates in this age group. We used logistic regression to estimate the relation between influenza infection and clinical symptoms. Statistical differences were considered significant for p-values \<0.05.

Ethical considerations {#sec014}
----------------------

The project was approved by the Senegalese National Ethics committee of the Ministry of Health and the assembled village population. Audits were done in 2013 by the National Ethics Committee of Senegal. During the first step of the cohort study, all inhabitants were given full information about the study and provided written informed consent before inclusion. Respiratory specimens were collected for diagnosis only after written informed consent was granted, and recorded in a dedicated form, to local health-care workers by the patients or by the parents of minors. This process has been accepted by the national Ethics committee.

Results {#sec015}
=======

For the 1036 inhabitants included in the cohort, 529,279 follow-up days were reported: 275,068 in Dielmo and 254,211 in Ndiop ([Table 1](#pone.0143999.t001){ref-type="table"}).

10.1371/journal.pone.0143999.t001

###### Characteristics and incidence rates in the villages of Dielmo and Ndiop---January 2012--December 2013.

![](pone.0143999.t001){#pone.0143999.t001g}

                                             Overall    Dielmo     Ndiop                        
  ------------------------------------------ ---------- ---------- -------- ---------- -------- -------------------------------------------
  Nb of inhabitants                          1,036      495        \(48\)   541        \(52\)   
  Nb of follow-up days                       529,279    275,068    \(52\)   254,211    \(48\)   
  Nb of patients                             543        271        \(50\)   272        \(50\)   
  Sex                                                                                           
  Male                                       261 (48)   140        \(52\)   121        \(44\)   0.40[\*](#t001fn001){ref-type="table-fn"}
  Female                                     282 (52)   131        \(48\)   151        \(56\)   
  Nb of fever episodes                       1129       586        \(52\)   543        \(48\)   
  Age                                                                                           
  Median                                     6.6        6.2                 6.8                 0.86^♭^
  IQR                                        \[12.1\]   \[11.9\]            \[12.5\]            
  Age groups                                                                                    
  \[0--6months)                              21 (2)     12         \(2\)    9          \(2\)    0.60[\*](#t001fn001){ref-type="table-fn"}
  \[6--24months)                             203 (18)   109        \(19\)   94         \(17\)   
  \[2--5 years)                              237 (21)   130        \(22\)   107        \(20\)   
  \[5--10 years)                             249 (22)   131        \(22\)   118        \(22\)   
  \[10--15 years)                            143 (13)   69         \(12\)   74         \(14\)   
  \[15--20 years)                            97 (9)     45         \(8\)    52         \(10\)   
  \[20--50years)                             139 (12)   66         \(11\)   73         \(13\)   
  \> = 50years                               40 (4)     24         \(4\)    16         \(3\)    
  Nb of fever episodes                                                                          
  1                                          268        128        \(49\)   140        \(52\)   0.25[\*](#t001fn001){ref-type="table-fn"}
  2                                          129        67         \(25\)   62         \(23\)   
  3                                          60         28         \(11\)   32         \(12\)   
  4                                          45         20         \(8\)    25         \(9\)    
  5                                          18         15         \(6\)    5          \(2\)    
  6 and more                                 11         5          \(2\)    6          \(2\)    
  Fever incidence rate (100 pers-year)       77.9       77.8                78.0                0.73♮
  Nb of ILI                                  598        341        \(57\)   257        \(43\)   
  ILI incidence rate (100 pers-year)         41.3       45.3                36.9                0.09♮
  Nb of influenza-positive samples           239        105        \(44\)   134        \(56\)   
  Influenza incidence rate (100 pers-year)   16.5       13.9                19.2                0.26♮
  Nb of malaria-positive tests               178        72         \(40\)   106        \(60\)   
  Malaria incidence rate (100 pers-year)     12.3       9.6                 15.2                0.12♮

\* Chi-squared test ^♭^Student\'s t-test ♮negative binomial regression univariate analysis

A total of 543 inhabitants were identified as febrile during the study period (271 from Dielmo and 272 from Ndiop); 282 (52%) were women and 261 (48%) were men (sex ratio M/F = 0.92 overall and 1.1 in Dielmo and 0.8 in Ndiop, p value = 0.40) ([Table 1](#pone.0143999.t001){ref-type="table"}).

A total of 1,129 episodes of fever were reported: 586 (52%) in Dielmo and 543 (48%) in Ndiop. Patient ages were 1 day to 83.6 years, with a median age of 6.6 years (6.2 years in Dielmo and 6.8 years in Ndiop; p-value = 0.86) ([Table 1](#pone.0143999.t001){ref-type="table"}). The distribution of fever episodes by age group did not differ significantly between the two villages ([Table 1](#pone.0143999.t001){ref-type="table"}).

The overall incidence rate of fever was 77.9 per 100 person-years. The fever incidence rates did not differ significantly between villages (p = 0.54), between years (p = 0.75) or between sexes (p = 0.35). Fever incidence rates differed significantly between age groups, with the \[6--24months) and \[0--6months) age groups having the highest incidence ([Table 2](#pone.0143999.t002){ref-type="table"}, Figs [1](#pone.0143999.g001){ref-type="fig"}, [2A](#pone.0143999.g002){ref-type="fig"} and [3A](#pone.0143999.g003){ref-type="fig"}, [S1](#pone.0143999.s001){ref-type="supplementary-material"} and [S2](#pone.0143999.s002){ref-type="supplementary-material"} Tables).

![Overall monthly incidence density rates for the two villages, 2012--2013.](pone.0143999.g001){#pone.0143999.g001}

![Monthly incidence density rates by age group in Dielmo, 2012--2013.](pone.0143999.g002){#pone.0143999.g002}

![Monthly incidence density rates by age group in Ndiop, 2012--2013.](pone.0143999.g003){#pone.0143999.g003}
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###### Incidence of fever syndromes, malaria cases, ILI and influenza infection in Dielmo and Ndiop, January 2012--December 2013.
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  ---------------- --------------------- ------------- ----------- --------------- ----------- ------------ ----------- ------------ ----------- ----------- ----------- -----------
  **DIELMO**       **Fever syndromes**   **Malaria**   **ILI**     **Influenza**                                                                                         
  **2012**         **Crude**             **95%CIs**    **Crude**   **95%CIs**      **Crude**   **95%CIs**   **Crude**   **95%CIs**                                       
  \[0--6months)    118.20                117.74        118.66      0.00            0.00        0.00         101.32      100.90       101.74      16.89       16.72       17.06
  \[6--24months)   287.44                287.00        287.88      0.00            0.00        0.00         222.12      221.73       222.51      39.20       39.04       39.36
  \[2--5years)     175.25                175.04        175.46      2.40            2.38        2.42         100.83      100.67       100.99      16.81       16.74       16.88
  \[5--10years)    102.46                102.33        102.59      8.00            7.96        8.04         57.63       57.53        57.73       16.01       15.96       16.06
  \[10--15years)   63.17                 63.06         63.28       7.90            7.86        7.94         29.61       29.53        29.69       13.82       13.77       13.87
  \[15--20years)   61.63                 61.50         61.76       5.36            5.32        5.40         45.55       45.44        45.66       5.36        5.32        5.40
  \[20--50yrs)     24.22                 24.17         24.27       2.79            2.77        2.81         12.11       12.08        12.14       1.86        1.85        1.87
  \> = 50years     17.80                 17.74         17.86       3.96            3.93        3.99         7.91        7.87         7.95        3.96        3.93        3.99
  Total            **74.89**             **74.84**     **74.94**   **4.58**        **4.57**    **4.59**     **44.99**   **44.95**    **45.03**   **9.97**    **9.95**    **9.99**
  **2013**                                                                                                                                                               
  \[0--6months)    73.43                 73.09         73.77       14.69           14.54       14.84        73.43       73.09        73.77       0.00        0.00        0.00
  \[6--24months)   334.57                334.14        335.00      0.00            0.00        0.00         236.77      236.41       237.13      66.91       66.72       67.10
  \[2--5years)     165.00                164.78        165.22      5.79            5.75        5.83         107.10      106.92       107.28      37.63       37.52       37.74
  \[5--10years)    97.91                 97.79         98.03       29.23           29.16       29.30        58.45       58.36        58.54       20.46       20.4        20.52
  \[10--15years)   74.53                 74.40         74.66       16.12           16.06       16.18        30.22       30.14        30.30       24.17       24.1        24.24
  \[15--20years)   58.92                 58.79         59.05       29.46           29.37       29.55        26.78       26.69        26.87       13.39       13.33       13.45
  \[20--50yrs)     36.16                 36.10         36.22       8.14            8.11        8.17         11.75       11.72        11.78       8.14        8.11        8.17
  \> = 50years     27.25                 27.18         27.32       7.27            7.23        7.31         14.54       14.49        14.59       3.63        3.60        3.66
  Total            **80.66**             **80.61**     **80.71**   **14.40**       **14.38**   **14.42**    **45.57**   **45.53**    **45.61**   **17.81**   **17.79**   **17.83**
  **NDIOP**        **Fever syndromes**   **Malaria**   **ILI**     **Influenza**                                                                                         
  **2012**         **Crude**             **95%CIs**    **Crude**   **95%CIs**      **Crude**   **95%CIs**   **Crude**   **95%CIs**                                       
  \[0--6months)    72.10                 71.77         72.43       0.00            0.00        0.00         57.68       57.38        57.98       28.84       28.63       29.05
  \[6--24months)   239.90                239.56        240.24      0.00            0.00        0.00         184.54      184.24       184.84      50.75       50.59       50.91
  \[2--5years)     116.63                116.45        116.81      0.00            0.00        0.00         95.42       95.26        95.58       29.16       29.07       29.25
  \[5--10years)    85.76                 85.64         85.88       8.41            8.37        8.45         55.49       55.39        55.59       25.22       25.15       25.29
  \[10--15years)   78.15                 78.00         78.30       13.47           13.41       13.53        35.03       34.93        35.13       24.25       24.17       24.33
  \[15--20years)   61.91                 61.78         62.04       33.54           33.44       33.64        23.22       23.14        23.30       10.32       10.27       10.37
  \[20--50yrs)     33.82                 33.76         33.88       5.28            5.26        5.30         12.68       12.64        12.72       6.34        6.31        6.37
  \> = 50years     14.49                 14.43         14.55       2.41            2.39        2.43         2.41        2.39         2.43        4.83        4.79        4.87
  Total            **71.95**             **71.90**     **72.00**   **8.59**        **8.57**    **8.61**     **43.82**   **43.78**    **43.86**   **17.77**   **17.75**   **17.79**
  **2013**                                                                                                                                                               
  \[0--6months)    40.69                 40.48         40.90       0.00            0.00        0.00         10.17       10.07        10.27       20.34       20.19       20.49
  \[6--24months)   181.98                181.69        182.27      8.67            8.61        8.73         108.32      108.10       108.54      30.33       30.21       30.45
  \[2--5years)     155.83                155.63        156.03      19.79           19.72       19.86        86.57       86.42        86.72       27.21       27.13       27.29
  \[5--10years)    107.11                106.98        107.24      28.77           28.70       28.84        43.16       43.07        43.25       33.57       33.49       33.65
  \[10--15years)   117.78                117.60        117.96      44.49           44.38       44.60        20.94       20.86        21.02       20.94       20.86       21.02
  \[15--20years)   70.15                 70.01         70.29       30.06           29.97       30.15        10.02       9.97         10.07       22.55       22.47       22.63
  \[20--50yrs)     41.47                 41.40         41.54       17.20           17.16       17.24        8.09        8.06         8.12        14.16       14.12       14.20
  \> = 50years     22.03                 21.96         22.10       6.61            6.57        6.65         2.20        2.18         2.22        4.41        4.38        4.44
  Total            **83.73**             **83.68**     **83.78**   **21.49**       **21.46**   **21.52**    **30.42**   **30.39**    **30.45**   **20.65**   **20.63**   **20.67**
  ---------------- --------------------- ------------- ----------- --------------- ----------- ------------ ----------- ------------ ----------- ----------- ----------- -----------

Data are cases per 100 person-years

Multivariate analysis including age group, month, year and village as independent variables indicated that fever incidence rates differed significantly between age groups, and between the months from October to December and the rest of the year. The highest risks were in the \[6--24month) and \[0--6month) age groups ([S2 Table](#pone.0143999.s002){ref-type="supplementary-material"}).

The most frequently reported associated clinical symptoms were asthenia (83%), headache (67%), cough (52%), and rhinitis (42%) ([Table 1](#pone.0143999.t001){ref-type="table"}). The distribution of the symptoms differed between the villages: asthenia, sweats, chills, anorexia and nausea were significantly more often reported in Ndiop; cough, sputum and rhinitis were more frequently reported in Dielmo ([Table 1](#pone.0143999.t001){ref-type="table"}).

A total of 598 influenza-like illnesses (ILI; 53% of febrile patients) were reported: 341 (57%) in Dielmo and 257 (43%) in Ndiop. The overall ILI incidence rate was 41.3 cases of ILI per 100 person-years, and did not differ significantly between the two villages (p = 0.06), between years (p = 0.15) ([Table 1](#pone.0143999.t001){ref-type="table"}), or between sexes (p = 0.34). The ILI incidence rates differed significantly between age groups, and were highest in the \[6--24 month) and \[0--6 month) age groups ([Table 2](#pone.0143999.t002){ref-type="table"}, Figs [1](#pone.0143999.g001){ref-type="fig"}, [2B](#pone.0143999.g002){ref-type="fig"} and [3B](#pone.0143999.g003){ref-type="fig"}, [S1](#pone.0143999.s001){ref-type="supplementary-material"} and [S2](#pone.0143999.s002){ref-type="supplementary-material"} Tables).

Multivariate analysis indicated significant differences in ILI incidence rates according to age group, month (April and from October to December) and village. The risk rates were in the \[6--24 month) and \[0--6 month) age groups (IRR = 16.1; 95%CI: \[11.1--23.3\] and IRR = 14.6; 95%CI: \[7.9--26.9\]) ([S2 Table](#pone.0143999.s002){ref-type="supplementary-material"}).

Plasmodium carriage was detected in 178 (16%) of the febrile patients: 72 (40%) in Dielmo and 106 (60%) in Ndiop. Among the positive malaria cases, 39 (21%) also presented with ILI symptoms. The malaria incidence rate was 12.3 episodes per 100 person-years during the period, and was not significantly different between the two villages (p = 0.14) or between sexes (p = 0.52). It was significantly higher in 2013 (21.5 cases per 100 person-years in Ndiop; 14.4 in Dielmo). The malaria incidence rate also differed significantly between age groups, being higher in the age groups \[10--15 year) and \[15--20 year) groups ([Table 2](#pone.0143999.t002){ref-type="table"}, [Fig 1](#pone.0143999.g001){ref-type="fig"}, [S1](#pone.0143999.s001){ref-type="supplementary-material"} and [S2](#pone.0143999.s002){ref-type="supplementary-material"} Tables).

Multivariate analysis indicated significant differences in the malaria incidence rates according to age group, the month (April and from October to December), the year and the village. The highest rates were in the \[15--20 year) age group (IRR = 3.3; 95%CI: \[2.1--5.3\]), in 2013 (IRR = 2.9; 95%CI: \[2.0--4.0\]), in November (IRR = 23.5; 95%CI: \[5.8--96.2\]), and in Ndiop (IRR = 1.6; 95%CI: \[1.1--2.1\]) ([S2 Table](#pone.0143999.s002){ref-type="supplementary-material"}).

A total of 949 specimens were collected from the 1,129 febrile patients (84%). Influenza A was identified in 158 specimens (17%) and Influenza B in 87 specimens (9%) ([Table 3](#pone.0143999.t003){ref-type="table"}).

10.1371/journal.pone.0143999.t003

###### Clinical symptoms associated with influenza infections in Dielmo and Ndiop, January 2012--December 2013.
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                     Influenza A   Influenza B                                                                               
  ------------------ ------------- ------------- ------- ----------------- -------- ---- -------- ------- ------------------ --------
  Asthenia           134           \(17\)        0.29    \[-0.43--0.60\]   0.27     72   \(9\)    0.09    \[-1.00--0.57\]    0.78
  Headache           118           \(19\)        0.60    \[0.09--0.83\]    0.03     60   \(10\)   -0.25   \[-1.50--0.44\]    0.68
  Sweat              25            \(20\)        0.23    \[-0.25--0.52\]   0.29     4    \(3\)    -2.33   \[-9.00---0.25\]   0.01
  Chills             45            \(19\)        0.17    \[-0.25--0.44\]   0.36     22   \(9\)    0.09    \[-0.67--0.41\]    0.82
  Feeling cold       48            \(19\)        0.09    \[-0.25--0.38\]   0.60     14   \(6\)    -1.00   \[-2.33---0.25\]   0.01
  Thirst             35            \(16\)        0.00    \[-0.67--0.33\]   0.92     22   \(10\)   -0.11   \[-0.67--0.44\]    0.82
  Cough              102           \(21\)        0.44    \[0.23--0.62\]    \<0.01   69   \(14\)   0.74    \[0.55--0.85\]     \<0.01
  Sputum             28            \(34\)        0.66    \[0.41--0.79\]    \<0.01   16   \(20\)   0.63    \[0.33--0.79\]     \<0.01
  Dyspnea            10            \(23\)        0.38    \[-0.43--0.69\]   0.23     7    \(17\)   0.52    \[-0.25--0.79\]    0.10
  Sore throat        13            \(33\)        0.62    \[0.23--0.80\]    \<0.01   5    \(13\)   0.33    \[-1.00--0.74\]    0.44
  Nasal congestion                                                                                                           
  Runny nose         82            \(20\)        0.33    \[0.09--0.52\]    0.03     58   \(14\)   0.64    \[0.41--0.78\]     \<0.01
  Stuffy nose        42            \(21\)        0.29    \[-0.11--0.52\]   0.06     35   \(18\)   0.66    \[0.44--0.78\]     \<0.01
  Anorexia           62            \(16\)        -0.11   \[-0.67--0.23\]   0.49     35   \(9\)    -0.11   \[-0.67--0.33\]    0.78
  Nausea             15            \(12\)        -0.67   \[-2.33--0.09\]   0.10     8    \(7\)    -0.67   \[-2.33--0.29\]    0.24
  Vomiting           21            \(13\)        -0.11   \[-1.00--0.33\]   0.63     6    \(4\)    -1.50   \[-4.00---0.11\]   0.03
  Diarrhea           13            \(13\)        -0.43   \[-1.50--0.23\]   0.31     7    \(7\)    -0.43   \[-2.33--0.38\]    0.41

EF: etiologic fraction

The overall flu incidence density rate was 19.2 per 100 person-years. The flu incidence density rates were not significantly different between villages (p = 0.32), years (p = 0.30) or between sexes (p = 0.78). The flu incidence density rates were significantly different between age groups, the highest being in the \[6--24 months) age group (30.3 to 50.7 per 100 person-years) ([Table 2](#pone.0143999.t002){ref-type="table"}, Figs [1](#pone.0143999.g001){ref-type="fig"}, [2C](#pone.0143999.g002){ref-type="fig"} and [3C](#pone.0143999.g003){ref-type="fig"}, [S1](#pone.0143999.s001){ref-type="supplementary-material"} and [S2](#pone.0143999.s002){ref-type="supplementary-material"} Tables).

Mutivariate analysis revealed significant differences in the flu incidence density rates between age groups, months (April, August and from October to December) and years. They were higher in the \[6--24 months) and \[0--6 months) age groups (IRR = 7.1; 95%CI: \[3.4--4.3\] and IRR = 9.9; 95%CI: \[2.9--33.6\]), in 2013 (IRR = 1.9; 95%CI: \[1.3--2.9\]), and in October (IRR = 10.3; 95%CI: \[3.4--30.9\]) ([S2 Table](#pone.0143999.s002){ref-type="supplementary-material"}).

Cough, sputum and rhinitis were associated with influenza A (RR = 1.8, 2.9 and 1.5, respectively) and B (RR = 3.9, 2.7 and 2.8, respectively) infections; sore throat (RR = 2.6) and headache (RR = 2.5) were associated with Influenza A infections and asthenia with both Influenza A (RR = 1.2) and Influenza B (RR = 1.2) infections ([Table 3](#pone.0143999.t003){ref-type="table"}).

If only ILI had been used as the criterion for sampling, 35% of the influenza A infections 20% of the Influenza B infections would not have been detected ([Table 4](#pone.0143999.t004){ref-type="table"}).

10.1371/journal.pone.0143999.t004

###### Distribution of the virus according to ILI definition, village and year, in Dielmo and Ndiop, January 2012--December 2013.

![](pone.0143999.t004){#pone.0143999.t004g}

                  Influenza A   Influenza B              
  --------------- ------------- ------------- ---------- ----------
  **Dielmo**                                             
      2012        2             12            2          21
                  \(14\)        \(86\)        \(9\)      \(91\)
      2013        18            37            5          13
                  \(33\)        \(67\)        \(28\)     \(72\)
      Total       **20**        **49**        **7**      **34**
                  **(29)**      **(71)**      **(17)**   **(83)**
  **Ndiop**                                              
      2012        6             35            3          16
                  \(15\)        \(85\)        \(16\)     \(84\)
      2013        29            19            7          20
                  \(60\)        \(40\)        \(26\)     \(74\)
      **Total**   **35**        **54**        **10**     **36**
                  **(39)**      **(61)**      **(22)**   **(78)**
  **Total**       **55**        **103**       **17**     **70**
  **(35)**        **(65)**      **(20)**      **(80)**   

Discussion {#sec016}
==========

This is the first study addressing fever syndromes, influenza-like illnesses and influenza infections reported over a substantial period of time by a small cohort established to study malaria. As previously described by Trape *et al*. \[[@pone.0143999.ref023]\] in Dielmo, the malaria incidence rates in both Dielmo and Ndiop were very low in comparison with the previous periods of the cohort study. Furthermore, we found that malaria rates were highest in the 5--20 year age group. Despite this malaria epidemiological profile, fever syndromes have remained relatively frequent (78 cases per 100 person-years); however, this is largely due to influenza-like illnesses (more than 50% of the cases of fever syndrome). Most such cases were in children under 5 years old. The aims of this study were to investigate the epidemiology of fever syndromes and among them influenza infection in an African rural setting. The motivation was to help reveal the influenza burden in Senegal and thereby to improve the knowledge that can contribute to policy decisions. The most important finding is that the largest proportion of the fever syndromes was not associated with malaria but with ILI and influenza infections. Also, the highest incidence rate of these influenza infections was in the \[6--24 month) age group. More than a third of the influenza infections were detected in non-ILI febrile patients. These observations are informative both on issues about influenza surveillance and flu disease burden.

Malaria is a major infectious disease in tropical Africa, and is believed to be the main cause of febrile episodes in children. Not surprisingly, therefore, influenza has received relatively little attention in Africa. The incidence of malaria and prevalence of *P*. *falciparum* have both declined recently in Dielmo \[[@pone.0143999.ref023]\] and Ndiop \[[@pone.0143999.ref025]\]. The results we report here are consistent with the trend described by Trape *et al* \[[@pone.0143999.ref023]\] and the incidence density of malaria attacks being less than 0.5 attacks per person-year in the \[10--15 years) age group (the group most often infected).

However, the incidence of fever syndromes remains high from October to December, corresponding to the seasonal malaria transmission period. Here, we report that the spread of influenza was also highest during this period probably in association with the end of the rainy seasons, consistent with observations in Brazil \[[@pone.0143999.ref026]\]. This type of temporal coincidence between malaria and respiratory infection during the rainy months has also been described elsewhere \[[@pone.0143999.ref027],[@pone.0143999.ref028]\].

However, we also found that influenza was present all year round, as in Rwanda \[[@pone.0143999.ref029]\]. Some studies in Senegal suggest seasonality with influenza peaks in July-August \[[@pone.0143999.ref008]\], but more recent data from the Senegalese sentinel surveillance network and findings in Gabon \[[@pone.0143999.ref030]\] are consistent with our results \[[@pone.0143999.ref004]\]. There is now ample evidence that influenza occurs throughout the year in tropical regions \[[@pone.0143999.ref013]\].

ILI and influenza incidence density rates were highest among the youngest children, both in Dielmo and Ndiop and in 2012 and 2013, consistent with existing knowledge about respiratory infections in Africa \[[@pone.0143999.ref021]\]. The highest risks of influenza infection were in \[0--6 month) and \[6--24 month) age groups, and were 7 to 10-fold higher than in 20 year-old and older age group. Our findings are generally consistent with results from Kenya \[[@pone.0143999.ref003]\], although the incidence rates we observed are higher than in the study in Kenya.

Our findings about fever syndromes, ILI and influenza infection suggest that prevention strategies should be targeted at children under five and probably younger (less than 24 months old). This would probably reduce the load of respiratory infection in this population and reduce mortality, consistent with the fourth millennium development goal.

Our study has several limitations. First, the diagnostic methods used for influenza virus have limitations: for example, 16% of the cases of fever syndrome were not sampled. These limitations could modify the estimated incidence rates. While we found that influenza was present year round, our study period of 24 months was too short to fully assess whether there are any seasonal patterns.

There may have been information bias concerning the clinical signs, and this may have affected the ILI classification of some fever syndromes and explain the percentage of positive influenza samples not related to ILI.

Conclusion {#sec017}
==========

In this rural setting in Senegal, the burden of malaria has decreased, but fever, ILI and influenza infection are clearly affecting the population previously affected by malaria: children under 5 years old. If preventive interventions are to be implemented, they certainly have to focus on this population and particularly children under 24 months old.
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###### Annual incidence rates according to age group and village (episodes per 100 person-months), Dielmo and Ndiop January 2012--December 2013.
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###### Results of the univariate and mutivariate binomial negative analyses, for Dielmo and Ndiop, January 2012--December 2013.
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